MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-14-2025
OptiNose Current Ratio 2011-2026 | OPTN
Annual Current Ratio OptiNose
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.554 | 0.718 | 0.884 | 3.46 | 4.65 | 8.28 | 16.1 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.1 | 0.554 | 4.95 |
Quarterly Current Ratio OptiNose
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.65 | 0.76 | 0.76 | 0.75 | 0.46 | 0.55 | 0.57 | 0.6 | 0.61 | 0.72 | 0.59 | 0.67 | 0.75 | 0.88 | 0.72 | 0.79 | 0.9 | 1.04 | 1.04 | 1.04 | 1.04 | 1.55 | 1.55 | 1.55 | 1.55 | 2.21 | 2.21 | 2.21 | 2.21 | 2.78 | 2.78 | 2.78 | 2.78 | 1.69 | 1.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.78 | 0.46 | 1.3 |
Current Ratio of other stocks in the Drug manufacturers industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
0.916 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
1.67 | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
1.85 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
5.85 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
2.34 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
1.95 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.944 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
0.961 | - | - | $ 754 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
1.47 | $ 5.86 | 1.56 % | $ 87 M | USA |
 |
Agile Therapeutics
AGRX
|
0.386 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.43 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
22.1 | $ 2.72 | -0.37 % | $ 1.04 B | Canada |
 |
Athenex
ATNX
|
0.894 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
1.15 | $ 34.43 | 0.76 % | $ 1.27 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
1.82 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
1.59 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
2.35 | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
1.01 | $ 5.39 | -0.19 % | $ 2 B | Canada |
 |
Pacira BioSciences
PCRX
|
2 | $ 24.04 | -1.31 % | $ 1.11 B | USA |
 |
Organogenesis Holdings
ORGO
|
3.63 | $ 2.66 | - | $ 337 M | USA |
 |
Canopy Growth Corporation
CGC
|
2.13 | $ 1.07 | 1.9 % | $ 115 M | Canada |
 |
Solid Biosciences
SLDB
|
4.43 | $ 7.02 | 2.03 % | $ 614 M | USA |
 |
Aurora Cannabis
ACB
|
3.49 | $ 3.47 | 0.29 % | $ 190 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
1.48 | $ 1.08 | 1.89 % | $ 1.34 M | USA |
 |
Jupiter Wellness
JUPW
|
6.86 | - | - | $ 33.6 M | USA |
 |
Tilray
TLRY
|
4.41 | $ 5.55 | 1.83 % | $ 3.43 B | Canada |
 |
Lannett Company
LCI
|
0.659 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
4 | $ 1.11 | - | $ 106 M | Canada |
 |
Evolus
EOLS
|
0.907 | $ 6.18 | -1.12 % | $ 398 M | USA |
 |
Sundial Growers
SNDL
|
5.69 | $ 1.45 | 0.69 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
1.66 | $ 9.0 | -1.42 % | $ 482 M | USA |
 |
cbdMD
YCBD
|
3.26 | $ 0.77 | 0.66 % | $ 3.1 M | USA |
 |
Veru
VERU
|
2.59 | $ 2.33 | 0.87 % | $ 34.1 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
12.2 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
1.54 | $ 23.41 | -0.21 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
3.65 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
0.418 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
2.4 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
12.5 | $ 7.26 | 1.26 % | $ 287 M | USA |
 |
Recro Pharma
REPH
|
1.62 | - | -4.76 % | $ 65.3 M | USA |
 |
SCYNEXIS
SCYX
|
6.12 | $ 0.7 | 2.92 % | $ 35 M | USA |
 |
PLx Pharma
PLXP
|
3.07 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
1.65 | $ 16.29 | 0.18 % | $ 19 B | USA |
 |
Zomedica Corp.
ZOM
|
10.9 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
5.98 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
2.83 | $ 0.76 | 1.14 % | $ 27.3 M | USA |
 |
Tricida
TCDA
|
1 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
3.75 | $ 0.75 | -1.04 % | $ 3.22 M |  China |
 |
TherapeuticsMD
TXMD
|
3.49 | $ 2.11 | - | $ 24.4 M | USA |